Member Info for WeTookPelham

...and/or large spread?

Https://www.msn.com/en-nz/health/other/mum-got-news-she-never-expected-after-suddenly-losing-her-hearing/ar-AA1aQxdJ

Article being syndicated.

Fingers crossed.

My pre weekend, very late Friday top up might have been well timed for a change!

Is it too late to say... "wouldn't want to be out of this over the weekend" ?

;)

My point, again, is that personally I can't see Dr. Ottensmier agreeing to give a quote without first running it past Scancell first. Likewise perhaps Trish had to run this past the Dr who had to then run past Scancell? Guess the only we will ever find out is emailing Scancell and asking them. Anyone want to do the honours?

But all IMO and I don't know how these things work in terms of clinical trials and media.

But isn't it amazing/interesting/clever how we're arguing about the articles source of approval and not the article itself?

P.s like you said in your ealier post: AB124

"...I'm no PR expert though."

AB124 - classic "balance" and deflection, as ever.

Isn't it odd you seem to see absolutely no positive to the article? Perhaps you could just appreciate the article for what it is?

A cynic would think you want the company to fail/price to tank? Not me obviously :)

But regardless of the source, authorsation etc, IMO it's a significant (first) release of mainstream media info aboutthe Modi trial. As mentioned there is a possibility it will be syndicated to other regionals and/or daily mirror.

https://www.liverpoolecho.co.uk/about-us/

https://www.reachplc.com/about-us

"Reach plc

Liverpoolecho.co.uk is published by Trinity Mirror North West & North Wales - a subsidiary company of Reach plc. Reach PLC is Britain's largest newspaper, magazine and digital publisher, with a print and online portfolio reaching 38.6million people every month."

Hi Rob, I was probably stating the obvious RE it being a sanctioned report, I think the point I was trying to make is that finally Scancell are ready to let the outside (mainstream) world know what they have and how the trials are progressing.

They clearly want the patient to talk about is virtues now.

The interesting question for me is why now. Also I wonder if the coronation weekend was a factor.

"...Her tumour is now half the size it was when Trish started taking the vaccine in September last year. Trish, who has a new grandson, George and another on the way, said: "The progress has been amazing.

"To have this kind of effect over such a short space of time gives you a lot of hope - and hope that this treatment can be there and be even better for people in the future.

"Although I was a nurse, I was community-based so did not get involved with clinical trials. So the whole process has been new to me. But everything was explained so thoroughly and I understood what was going to happen to me.

"I feel absolutely brilliant – it is the easiest treatment I've ever had. There have been no real side-effects. And this is one of the remarkable things, that it has been a total breeze compared to other cancer treatments, such as chemotherapy and radiotherapy.

"When I was a paediatric nurse, I saw the effects that chemotherapy had on children. To think that this new treatment could become standard is really amazing."

The fact that Dr Ottensmier is quoted would imply a Scancell approved article. An element of de-cloaking by Scancell? Finally?

Https://www.liverpoolecho.co.uk/news/health/mum-news-never-expected-after-26852352

I assume this will be syndicated around other regional newspapers too .

"...Something has to be going on in the background as 2023 has generally been extremely quiet"

Extremely quiet even compared to Scancell's normal standards. But yes, something must be going on in the background that they cannot yet discuss, you'd think!?

...buy a few more in anticipation.
Scancell some news please!

Speaking of other uses, could the science experts comment on the use of Scancell's monoclonal antibodies with Alzheimer's etc.

https://www.pharmaceutical-technology.com/comment/monoclonal-antibodies-alzheimers/

We had big news this week:
https://www.nature.com/articles/d41586-023-01537-5

Yes always worth checking the Macmillan forum,
I search for 'modi', 'scancell' in the search box and make sure to select 'eveywhere' as the search criteria.

Seems to be a increase in chatter about the trial IMO.

A rare non RNS linked tweet, and on the weekend. At least finally some signs of life RE Comms perhaps.

Ah I did not realise CW. Best of luck whatever the reason is.

CW, I see your post is actually a copy and paste from the McMillan thread from that user looking to be enrolled on the trial. This might not actually clear to those on lse. Thanks though, very useful know.

As I say jb7070, mine is purely a guess, someone more knowledgeable will no doubt have correct answer.

****Either way, that 'completion' wording is significant is it not?

RE 'Report after completion of monotherapy dose' - my assumption is that by time of ASCO it will report findings of the completed monotherapy dose (only?), and by that time the CPI combo should(?) be well under way but that will not be under the scope of the ASCO report?

But i'm just guessing.

Either that 'completion' wording is significant is it not?

Dr Christian O, has some big name connections all of his own it seems?

IMO seems totally unfeasible that Bristol, Merck etc are not fully aware about Scancell and their wares.

In fact your whole post "links directly to poster/abstact Today 07:36" was fascinating reading.